<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Mounjaro and Zepbound Guide: A Doctor's 2025 Comparison of Tirzepatide</title>
    <meta name="description" content="Complete physician-reviewed guide to Mounjaro and Zepbound (tirzepatide): how they work, weight loss results, side effects, and clinical insights from Dr. Brian Mubangwa, internal medicine physician.">
    
    <!-- Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:opsz,wght@14..32,400;14..32,500;14..32,600;14..32,700&family=Merriweather:wght@400;700&display=swap" rel="stylesheet">
    
    <!-- Tailwind -->
    <script src="https://cdn.tailwindcss.com"></script>
    
    <!-- AdSense -->
    <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1751735847396167" crossorigin="anonymous"></script>
    
    <style>
        body { font-family: 'Inter', sans-serif; background: #f9fafb; }
        h1, h2, h3 { font-family: 'Merriweather', serif; }
        .doctor-callout { background: #e6f3ff; border-left: 4px solid #2563eb; }
        .comparison-table th { background: #0b3b5c; color: white; padding: 12px; }
        .comparison-table td { padding: 12px; border-bottom: 1px solid #e2e8f0; }
        .comparison-table tr:hover { background: #f8fafc; }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="bg-white shadow-sm sticky top-0 z-50">
        <div class="max-w-7xl mx-auto px-4">
            <div class="flex justify-between items-center h-16">
                <a href="index.html" class="text-2xl font-bold">
                    <span class="text-blue-600">Health</span><span class="text-gray-800">Hub</span>
                </a>
                <nav class="hidden md:flex space-x-8">
                    <a href="index.html" class="text-gray-600 hover:text-gray-900">Home</a>
                    <a href="about.html" class="text-gray-600 hover:text-gray-900">About Dr. Mubangwa</a>
                    <a href="contact.html" class="text-gray-600 hover:text-gray-900">Contact</a>
                    <a href="privacy-policy.html" class="text-gray-600 hover:text-gray-900">Privacy</a>
                </nav>
            </div>
        </div>
    </header>

    <!-- Article Container -->
    <main class="max-w-4xl mx-auto px-4 py-8">
        <!-- Article Header -->
        <div class="mb-6">
            <div class="flex items-center gap-2 text-sm text-purple-600 mb-2">
                <span>üî• Trending</span>
                <span>‚Ä¢</span>
                <span>Weight Management</span>
                <span>‚Ä¢</span>
                <span>Updated February 2025</span>
            </div>
            <h1 class="text-3xl md:text-4xl font-bold text-gray-900 mb-4">Mounjaro and Zepbound Guide: A Doctor's 2025 Comparison of Tirzepatide</h1>
            <div class="flex items-center gap-4">
                <div class="w-10 h-10 bg-blue-100 rounded-full flex items-center justify-center">
                    üë®‚Äç‚öïÔ∏è
                </div>
                <div>
                    <p class="font-medium">Dr. Brian Mubangwa, MD</p>
                    <p class="text-sm text-gray-500">Internal Medicine Physician</p>
                </div>
            </div>
        </div>

        <!-- Featured Image -->
        <img src="https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?auto=format&fit=crop&w=1200&q=80" 
             alt="Mounjaro and Zepbound medications" 
             class="w-full rounded-2xl mb-8">

        <!-- Ad (Top of Article) -->
        <div class="my-6">
            <ins class="adsbygoogle"
                 style="display:block"
                 data-ad-client="ca-pub-1751735847396167"
                 data-ad-slot="9698066978"
                 data-ad-format="auto"
                 data-full-width-responsive="true"></ins>
            <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
        </div>

        <!-- Article Content -->
        <article class="prose prose-lg max-w-none">
            <!-- KEY TAKEAWAYS -->
            <div class="bg-purple-50 p-6 rounded-xl not-prose mb-8">
                <h3 class="text-lg font-bold text-purple-900 mb-3">üìã Key Takeaways</h3>
                <ul class="space-y-2 text-gray-800">
                    <li class="flex items-start gap-2">
                        <span class="text-purple-600">‚úì</span>
                        <span><strong>Mounjaro and Zepbound are the same drug (tirzepatide)</strong> ‚Äì different names for different indications</span>
                    </li>
                    <li class="flex items-start gap-2">
                        <span class="text-purple-600">‚úì</span>
                        <span><strong>Average weight loss: 20-22% of body weight</strong> ‚Äì the most effective weight loss medication currently available</span>
                    </li>
                    <li class="flex items-start gap-2">
                        <span class="text-purple-600">‚úì</span>
                        <span><strong>Dual action:</strong> Targets both GLP-1 and GIP receptors, making it more potent than Ozempic/Wegovy</span>
                    </li>
                    <li class="flex items-start gap-2">
                        <span class="text-purple-600">‚úì</span>
                        <span><strong>Side effects similar to other GLP-1 drugs</strong> ‚Äì nausea, vomiting, diarrhea ‚Äì but often more pronounced</span>
                    </li>
                </ul>
            </div>

            <h2>Introduction</h2>
            <p>"Is Mounjaro better than Ozempic for weight loss?"</p>
            
            <p>This is the most common question I've heard in my clinic over the past year. And for good reason ‚Äì tirzepatide (the drug in Mounjaro and Zepbound) has produced the most dramatic weight loss results we've ever seen from a medication.</p>
            
            <p>But there's confusion. Why two names? Which one is for diabetes? Which for weight loss? Is it covered by insurance? And most importantly ‚Äì is it right for you?</p>
            
            <p>In this guide, I'll explain everything my patients need to know:</p>
            <ul>
                <li>The difference between Mounjaro and Zepbound</li>
                <li>How tirzepatide works (and why it's different from Ozempic)</li>
                <li>Clinical trial results ‚Äì what you can realistically expect</li>
                <li>Side effects and how to manage them</li>
                <li>Cost and insurance coverage</li>
                <li>Who is a good candidate</li>
                <li>What happens when you stop</li>
            </ul>

            <!-- In-Article Ad -->
            <div class="my-8 not-prose">
                <ins class="adsbygoogle"
                     style="display:block; text-align:center;"
                     data-ad-layout="in-article"
                     data-ad-format="fluid"
                     data-ad-client="ca-pub-1751735847396167"
                     data-ad-slot="9698066978"></ins>
                <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
            </div>

            <h2>Mounjaro vs. Zepbound: What's the Difference?</h2>
            <p>This confuses many patients, so let's make it crystal clear:</p>
            
            <div class="bg-white p-6 rounded-xl border not-prose my-6">
                <div class="grid md:grid-cols-2 gap-6">
                    <div class="text-center p-4 bg-blue-50 rounded-xl">
                        <span class="text-3xl">üíâ</span>
                        <h3 class="font-bold text-xl mt-2">Mounjaro</h3>
                        <p class="text-sm text-gray-600 mt-1"><strong>Approved for:</strong> Type 2 diabetes</p>
                        <p class="text-sm"><strong>Active ingredient:</strong> Tirzepatide</p>
                        <p class="text-sm"><strong>Manufacturer:</strong> Eli Lilly</p>
                        <p class="text-xs mt-2">Same drug, different label</p>
                    </div>
                    <div class="text-center p-4 bg-purple-50 rounded-xl">
                        <span class="text-3xl">üíä</span>
                        <h3 class="font-bold text-xl mt-2">Zepbound</h3>
                        <p class="text-sm text-gray-600 mt-1"><strong>Approved for:</strong> Weight management</p>
                        <p class="text-sm"><strong>Active ingredient:</strong> Tirzepatide</p>
                        <p class="text-sm"><strong>Manufacturer:</strong> Eli Lilly</p>
                        <p class="text-xs mt-2">Same drug, different label</p>
                    </div>
                </div>
                <p class="text-center mt-4 text-sm bg-yellow-50 p-2 rounded-lg"><strong>They are EXACTLY the same medication.</strong> The only difference is the FDA-approved indication and labeling.</p>
            </div>

            <h2>How Tirzepatide Works</h2>
            <p>This is where tirzepatide differs from Ozempic/Wegovy (semaglutide).</p>
            
            <div class="grid md:grid-cols-2 gap-4 not-prose my-6">
                <div class="bg-white p-5 rounded-xl border">
                    <span class="text-2xl">üéØ</span>
                    <h3 class="font-bold mt-2">Ozempic/Wegovy</h3>
                    <p class="text-sm">Targets <strong>one</strong> receptor: GLP-1</p>
                    <p class="text-xs text-gray-600 mt-2">Appetite suppression, slower stomach emptying</p>
                </div>
                <div class="bg-purple-50 p-5 rounded-xl border-2 border-purple-200">
                    <span class="text-2xl">üéØüéØ</span>
                    <h3 class="font-bold mt-2">Mounjaro/Zepbound</h3>
                    <p class="text-sm">Targets <strong>two</strong> receptors: GLP-1 <strong>AND</strong> GIP</p>
                    <p class="text-xs text-gray-600 mt-2">GIP enhances the effects of GLP-1, leading to greater weight loss and better blood sugar control</p>
                </div>
            </div>
            
            <p><strong>Think of it this way:</strong> If GLP-1 is a volume knob, GIP is a second speaker. Together, they create a more powerful signal for appetite suppression and metabolic improvement.</p>

            <h2>Clinical Results: What You Can Expect</h2>
            <p>The SURMOUNT clinical trials produced remarkable results:</p>
            
            <div class="bg-white p-6 rounded-xl border not-prose my-6">
                <h3 class="font-bold text-lg mb-3">SURMOUNT-1 Trial (72 weeks)</h3>
                <div class="space-y-3">
                    <div class="flex justify-between items-center">
                        <span><strong>5 mg dose:</strong></span>
                        <span class="font-bold text-green-600">15% body weight loss</span>
                    </div>
                    <div class="flex justify-between items-center">
                        <span><strong>10 mg dose:</strong></span>
                        <span class="font-bold text-green-600">19.5% body weight loss</span>
                    </div>
                    <div class="flex justify-between items-center">
                        <span><strong>15 mg dose:</strong></span>
                        <span class="font-bold text-green-600">20.9% body weight loss</span>
                    </div>
                    <div class="flex justify-between items-center border-t pt-2">
                        <span><strong>Placebo (diet/exercise only):</strong></span>
                        <span class="font-bold">3.1% body weight loss</span>
                    </div>
                </div>
                <p class="text-sm mt-4 bg-green-50 p-3 rounded-lg">For a 200 lb person, that's <strong>30-42 lbs lost</strong> on average.</p>
            </div>
            
            <p><strong>Even more impressive:</strong> One-third of patients lost more than 25% of their body weight ‚Äì that's 50+ lbs for a 200 lb person. This is unprecedented for a medication.</p>

            <!-- In-Article Ad -->
            <div class="my-8 not-prose">
                <ins class="adsbygoogle"
                     style="display:block"
                     data-ad-client="ca-pub-1751735847396167"
                     data-ad-slot="9698066978"
                     data-ad-format="auto"
                     data-full-width-responsive="true"></ins>
                <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
            </div>

            <h2>Comparison: Tirzepatide vs. Semaglutide</h2>
            <p>Here's how Mounjaro/Zepbound stacks up against Ozempic/Wegovy:</p>
            
            <div class="table-container not-prose my-8 overflow-x-auto">
                <table class="comparison-table min-w-full bg-white rounded-xl border">
                    <thead>
                        <tr>
                            <th>Medication</th>
                            <th>Active Ingredient</th>
                            <th>Targets</th>
                            <th>Average Weight Loss</th>
                            <th>Dosing</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Mounjaro/Zepbound</strong></td>
                            <td>Tirzepatide</td>
                            <td>GLP-1 + GIP</td>
                            <td class="font-bold text-green-600">20-22%</td>
                            <td>Weekly injection</td>
                        </tr>
                        <tr>
                            <td><strong>Ozempic/Wegovy</strong></td>
                            <td>Semaglutide</td>
                            <td>GLP-1 only</td>
                            <td>15%</td>
                            <td>Weekly injection</td>
                        </tr>
                        <tr>
                            <td><strong>Saxenda</strong></td>
                            <td>Liraglutide</td>
                            <td>GLP-1 only</td>
                            <td>5-8%</td>
                            <td>Daily injection</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            
            <p><strong>The bottom line:</strong> Tirzepatide is more effective for weight loss than any other medication currently available.</p>

            <h2>Who Is a Good Candidate?</h2>
            
            <div class="grid md:grid-cols-2 gap-4 not-prose my-6">
                <div class="bg-green-50 p-5 rounded-xl">
                    <h3 class="font-bold text-green-800">‚úÖ Mounjaro (diabetes)</h3>
                    <ul class="list-disc list-inside text-sm mt-2">
                        <li>Type 2 diabetes diagnosis</li>
                        <li>BMI ‚â•27 (overweight)</li>
                        <li>Inadequate control on other medications</li>
                    </ul>
                </div>
                <div class="bg-green-50 p-5 rounded-xl">
                    <h3 class="font-bold text-green-800">‚úÖ Zepbound (weight loss)</h3>
                    <ul class="list-disc list-inside text-sm mt-2">
                        <li>BMI ‚â•30 (obesity)</li>
                        <li>BMI ‚â•27 with weight-related condition (hypertension, diabetes, sleep apnea, etc.)</li>
                        <li>Failed previous weight loss attempts</li>
                    </ul>
                </div>
            </div>
            
            <div class="bg-red-50 p-5 rounded-xl not-prose my-4">
                <h3 class="font-bold text-red-800">‚ùå Not good candidates:</h3>
                <ul class="list-disc list-inside text-sm mt-2">
                    <li>Personal/family history of medullary thyroid cancer</li>
                    <li>MEN2 syndrome</li>
                    <li>History of pancreatitis</li>
                    <li>Pregnancy/breastfeeding</li>
                    <li>Severe gastroparesis</li>
                </ul>
            </div>

            <div class="doctor-callout p-6 rounded-xl not-prose my-8">
                <h4 class="font-bold text-blue-900 mb-2">üë®‚Äç‚öïÔ∏è Dr. Mubangwa's Clinical Note</h4>
                <p class="text-gray-800">I'm seeing more patients asking for tirzepatide specifically because of the impressive trial results. But remember: stronger effect often means stronger side effects, at least initially. Start low, go slow.</p>
            </div>

            <h2>Side Effects: What to Expect</h2>
            <p>Side effects are similar to other GLP-1 drugs but can be more intense due to the dual mechanism.</p>
            
            <h3>Very Common (>20%)</h3>
            <ul>
                <li><strong>Nausea</strong> ‚Äì most common, especially at dose increases</li>
                <li><strong>Diarrhea</strong></li>
                <li><strong>Vomiting</strong></li>
                <li><strong>Constipation</strong></li>
                <li><strong>Decreased appetite</strong> (desired effect, but can be intense)</li>
            </ul>
            
            <h3>Common (5-20%)</h3>
            <ul>
                <li>Abdominal pain</li>
                <li>Indigestion</li>
                <li>Fatigue</li>
                <li>Injection site reactions</li>
            </ul>
            
            <h3>Rare but Serious</h3>
            <ul>
                <li>Pancreatitis</li>
                <li>Gallbladder disease (gallstones)</li>
                <li>Acute kidney injury (from dehydration)</li>
                <li>Severe hypoglycemia (especially with other diabetes meds)</li>
                <li>Thyroid C-cell tumors (in rats; human risk unclear)</li>
            </ul>

            <h2>Managing Side Effects</h2>
            <p>Here's what I tell my patients starting tirzepatide:</p>
            
            <div class="bg-white p-6 rounded-xl border not-prose my-6">
                <h3 class="font-bold">üìÖ First Month Survival Guide</h3>
                <ul class="space-y-2 mt-3">
                    <li><strong>Start at the lowest dose (2.5 mg)</strong> and stay there for 4 weeks</li>
                    <li><strong>Inject before bed</strong> ‚Äì sleep through the initial nausea peak</li>
                    <li><strong>Eat smaller, more frequent meals</strong> ‚Äì avoid large portions</li>
                    <li><strong>Avoid fatty, greasy foods</strong> ‚Äì they worsen nausea</li>
                    <li><strong>Stay hydrated</strong> ‚Äì sip water throughout the day</li>
                    <li><strong>Consider anti-nausea medication</strong> if needed (ask your doctor)</li>
                    <li><strong>Give it time</strong> ‚Äì most side effects improve within 4 weeks</li>
                </ul>
            </div>

            <!-- In-Article Ad -->
            <div class="my-8 not-prose">
                <ins class="adsbygoogle"
                     style="display:block; text-align:center;"
                     data-ad-layout="in-article"
                     data-ad-format="fluid"
                     data-ad-client="ca-pub-1751735847396167"
                     data-ad-slot="9698066978"></ins>
                <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
            </div>

            <h2>Cost and Insurance Coverage</h2>
            
            <table class="min-w-full border my-6">
                <tr><th class="bg-gray-100 p-2">Scenario</th><th class="bg-gray-100 p-2">Typical Cost</th></tr>
                <tr><td class="p-2 border">Without insurance</td><td class="p-2 border">$1,000-1,200/month</td></tr>
                <tr><td class="p-2 border">With insurance (diabetes)</td><td class="p-2 border">$25-50 copay common</td></tr>
                <tr><td class="p-2 border">With insurance (weight loss)</td><td class="p-2 border">Often not covered; prior authorization may help</td></tr>
                <tr><td class="p-2 border">Manufacturer savings card</td><td class="p-2 border">As low as $25/month for eligible patients</td></tr>
            </table>
            
            <p><strong>Important:</strong> Insurance coverage for Zepbound (weight loss) is evolving. Many plans now cover it, but often require prior authorization and documentation of failed weight loss attempts.</p>

            <h2>What Happens When You Stop?</h2>
            <p>The SURMOUNT-4 trial looked at this:</p>
            
            <ul>
                <li>Patients who continued tirzepatide maintained weight loss</li>
                <li>Patients switched to placebo regained <strong>14% of body weight</strong> within a year</li>
            </ul>
            
            <p><strong>The reality:</strong> Like all weight loss medications, tirzepatide treats a chronic condition. Stop the medication, and the underlying biology returns. Most patients need long-term treatment to maintain results.</p>

            <h2>Frequently Asked Questions</h2>
            
            <div class="space-y-4 my-6">
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: Is Mounjaro better than Ozempic for weight loss?</p>
                    <p class="text-gray-700 mt-1">A: Yes, clinical trials show tirzepatide produces greater weight loss (20-22% vs. 15% for semaglutide). It's the most effective weight loss medication currently available.</p>
                </div>
                
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: Can I take Mounjaro if I don't have diabetes?</p>
                    <p class="text-gray-700 mt-1">A: Yes, but it would be "off-label" (not FDA-approved for that use). Zepbound is the same medication approved specifically for weight loss. Many doctors prescribe Mounjaro off-label for weight loss, but insurance may not cover it.</p>
                </div>
                
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: How fast will I lose weight?</p>
                    <p class="text-gray-700 mt-1">A: Most lose 1-2 lbs weekly initially. The full effect builds over months as you increase to therapeutic doses. By 6-9 months, you'll see the full results.</p>
                </div>
                
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: Will I be nauseous forever?</p>
                    <p class="text-gray-700 mt-1">A: Usually not. Most nausea improves within 4 weeks at each dose level. If it persists, your doctor can adjust the dose or add anti-nausea medication.</p>
                </div>
                
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: Can I drink alcohol?</p>
                    <p class="text-gray-700 mt-1">A: Yes, but cautiously. Alcohol can worsen nausea and dehydration. Limit intake, especially when starting.</p>
                </div>
                
                <div class="bg-gray-50 p-4 rounded-lg">
                    <p class="font-semibold">Q: Is hair loss common?</p>
                    <p class="text-gray-700 mt-1">A: Yes ‚Äì with any rapid weight loss, temporary telogen effluvium (hair shedding) can occur. It's usually temporary. Adequate protein intake helps.</p>
                </div>
            </div>

            <h2>When to See a Doctor</h2>
            <ul>
                <li>Severe abdominal pain (possible pancreatitis)</li>
                <li>Persistent vomiting (dehydration risk)</li>
                <li>Signs of allergic reaction</li>
                <li>Vision changes</li>
                <li>Severe hypoglycemia (if also on insulin/sulfonylureas)</li>
            </ul>

            <h2>Doctor's Bottom Line</h2>
            <p>Tirzepatide (Mounjaro/Zepbound) represents a major advance in weight loss treatment. For the first time, we have a medication that can produce weight loss comparable to bariatric surgery ‚Äì 20% or more of body weight.</p>
            
            <p>But it's not magic. It requires commitment to lifestyle changes, patience with side effects, and understanding that it's likely a long-term treatment.</p>
            
            <p>If you're considering tirzepatide, have an honest conversation with your doctor about:</p>
            <ul>
                <li>Your weight loss goals</li>
                <li>Potential side effects</li>
                <li>Cost and insurance coverage</li>
                <li>Realistic expectations</li>
            </ul>
            
            <p>For the right patient, this medication can be truly life-changing.</p>

            <!-- References -->
            <h3>References</h3>
            <ul class="text-sm text-gray-600">
                <li>Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.</li>
                <li>Frias JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515.</li>
                <li>FDA. Mounjaro (tirzepatide) prescribing information. 2022.</li>
                <li>FDA. Zepbound (tirzepatide) prescribing information. 2023.</li>
            </ul>

            <!-- Medical Disclaimer -->
            <div class="bg-gray-100 p-4 rounded-lg text-sm text-gray-600 not-prose mt-8">
                <strong>Medical Disclaimer:</strong> This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
            </div>
        </article>

        <!-- Bottom Ad -->
        <div class="my-8">
            <ins class="adsbygoogle"
                 style="display:block"
                 data-ad-client="ca-pub-1751735847396167"
                 data-ad-slot="9698066978"
                 data-ad-format="auto"
                 data-full-width-responsive="true"></ins>
            <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
        </div>

        <!-- Related Articles -->
        <div class="bg-white rounded-2xl border p-6 mt-8">
            <h3 class="text-xl font-bold mb-4">You May Also Like</h3>
            <div class="grid sm:grid-cols-2 gap-4">
                <a href="ozempic-for-weightloss.html" class="flex items-center gap-3 p-3 hover:bg-gray-50 rounded-lg">
                    <span class="text-2xl">üíâ</span>
                    <span>Ozempic for Weight Loss Guide</span>
                </a>
                <a href="diabetes-treatment-guide.html" class="flex items-center gap-3 p-3 hover:bg-gray-50 rounded-lg">
                    <span class="text-2xl">ü©∏</span>
                    <span>Type 2 Diabetes Treatment Guide</span>
                </a>
                <a href="preventing-type-2-diabetes.html" class="flex items-center gap-3 p-3 hover:bg-gray-50 rounded-lg">
                    <span class="text-2xl">üõ°Ô∏è</span>
                    <span>Preventing Type 2 Diabetes</span>
                </a>
                <a href="lower-cholesterol.html" class="flex items-center gap-3 p-3 hover:bg-gray-50 rounded-lg">
                    <span class="text-2xl">üìä</span>
                    <span>Lower Cholesterol Naturally</span>
                </a>
            </div>
        </div>
    </main>

    <!-- Footer -->
    <footer class="bg-gray-900 text-white mt-16">
        <div class="max-w-7xl mx-auto px-4 py-12">
            <div class="grid md:grid-cols-4 gap-8">
                <div>
                    <h3 class="text-lg font-bold mb-4">HealthHub</h3>
                    <p class="text-gray-400 text-sm">Evidence-based health information written by Dr. Brian Mubangwa, internal medicine physician.</p>
                </div>
                <div>
                    <h4 class="font-semibold mb-3">Quick Links</h4>
                    <ul class="space-y-2 text-sm text-gray-400">
                        <li><a href="index.html" class="hover:text-white">Home</a></li>
                        <li><a href="about.html" class="hover:text-white">About Dr. Mubangwa</a></li>
                        <li><a href="contact.html" class="hover:text-white">Contact</a></li>
                        <li><a href="privacy-policy.html" class="hover:text-white">Privacy Policy</a></li>
                    </ul>
                </div>
                <div>
                    <h4 class="font-semibold mb-3">Categories</h4>
                    <ul class="space-y-2 text-sm text-gray-400">
                        <li><a href="#" class="hover:text-white">Weight Management</a></li>
                        <li><a href="#" class="hover:text-white">Diabetes</a></li>
                        <li><a href="#" class="hover:text-white">Heart Health</a></li>
                        <li><a href="#" class="hover:text-white">Prevention</a></li>
                    </ul>
                </div>
                <div>
                    <h4 class="font-semibold mb-3">Medical Disclaimer</h4>
                    <p class="text-sm text-gray-400">This site is for educational purposes only. No doctor-patient relationship is established. Always consult your physician.</p>
                </div>
            </div>
            <div class="border-t border-gray-800 mt-8 pt-8 text-center text-gray-400 text-sm">
                ¬© 2025 HealthHub. All content written by Dr. Brian Mubangwa, MD.
            </div>
        </div>
    </footer>

    <script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
</body>
</html>
